Document is current
Any future updates will be listed below
-
Authors
Bartsch, Rupert http://orcid.org/0000-0002-4384-6917
-
Funding
Funding for this research was provided by:
Medizinische Universität Wien
-
License Information
Text and Data Mining valid from 2021-01-24
Version of Record valid from 2021-01-24
-
More Information
Article History
Received: 5 October 2020
Accepted: 4 January 2021
First Online: 24 January 2021
Conflict of interest
: R. Bartsch: Advisory Role: Astra-Zeneca, Celgene, Daiichi, Eisai, Eli-Lilly, MSD, Novartis, Pfizer, Pierre-Fabre, Puma, Roche, Samsung; Lecture Honoraria: Accord, Astra-Zeneca, BMS, Celgene, Eli-Lilly, Novartis, Pfizer, Pierre-Fabre, Roche, Sandoz; Research Support: Daiichi, MSD, Novartis, Roche.
